LOW-DOSE CYTARABINE - COMPLETE REMISSION IN A PATIENT WITH ACUTE MYELOID-LEUKEMIA IN RELAPSE SUGGESTING A DIFFERENTIATION EFFECT

被引：0
|
作者：
ABBADESSA, A [1 ]
BRUZZESE, L [1 ]
ARCIDIACONE, G [1 ]
机构：
[1] FAC MED & CHIRURG NAPOLI 1,MED CLIN,NAPOLI,ITALY
来源：
ACTA HAEMATOLOGICA | 1987年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：211 / 212
页数：2
相关论文
共 50 条
  • [41] TREATMENT OF RELAPSED ACUTE MYELOID-LEUKEMIA WITH IDARUBICIN AND INTERMEDIATE-DOSE CYTARABINE
    HAROUSSEAU, JL
    REIFFERS, J
    HURTELOUP, P
    MILPIED, N
    GUY, H
    RIGALHUGUET, F
    FACON, T
    DUFOUR, P
    IFRAH, N
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 45 - 49
  • [42] Comparison of Condensed to Standard Schedule of High Dose Cytarabine Consolidation for Acute Myeloid Leukemia in First Complete Remission
    Solh, Melhem M.
    Kilby, Kristen
    Baron, Jimena
    Zhang, Xu
    Bashey, Asad
    Holland, H. Kent
    Bachier-Rodriguez, Lizamarie
    Morris, Lawrence
    Solomon, Scott R.
    BLOOD, 2023, 142
  • [43] Durable clinical and cytogenetic remission in an elderly patient with relapsed acute myeloid leukemia treated with low-dose lenalidomide
    Basile, Frank G.
    LEUKEMIA & LYMPHOMA, 2009, 50 (04) : 653 - 655
  • [44] LOW-DOSE CYTOSINE-ARABINOSIDE FOR TREATMENT OF ACUTE MYELOID-LEUKEMIA - 3 CASES
    ANDREY, C
    BERIS, P
    PLANCHEREL, C
    DELOES, S
    MAURICE, P
    CHAPUIS, B
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1983, 113 (27-2) : 980 - 984
  • [45] LOW-DOSE CYTOSINE-ARABINOSIDE THERAPY IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID-LEUKEMIA
    KATAYAMA, N
    TANAKA, I
    MINAMI, N
    SHIRAKAWA, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1987, 17 (02) : 117 - 121
  • [46] Arsenic Trioxide and Low-dose Cytarabine in Older Patients With Untreated Acute Myeloid Leukemia, Excluding Acute Promyelocytic Leukemia
    Roboz, Gail J.
    Ritchie, Ellen K.
    Curcio, Tania
    Provenzano, Juliette
    Carlin, Rebecca
    Samuel, Michael
    Wittenberg, Beth
    Mazumdar, Madhu
    Christos, Paul J.
    Mathew, Susan
    Allen-Bard, Sandra
    Feldman, Eric J.
    CANCER, 2008, 113 (09) : 2504 - 2511
  • [47] LOW-DOSE INTERFERON-ALPHA IN CHRONIC MYELOID-LEUKEMIA
    TALPAZ, M
    KANTARJIAN, H
    ANNALS OF INTERNAL MEDICINE, 1995, 122 (09) : 728 - 728
  • [48] Clinical Benefit of Glasdegib in Combination with Azacitidine or Low-Dose Cytarabine in Patients with Acute Myeloid Leukemia
    Zeidan, Amer M.
    Schuster, Michael W.
    Krauter, Jurgen
    Maertens, Johan A.
    Gyan, Emmanuel
    Joris, Magalie
    Menne, Tobias F.
    Vyas, Paresh
    Ma, Weidong Wendy
    O'Connell, Ashleigh
    Zeremski, Mirjana
    Kudla, Arthur
    Chan, Geoffrey
    Sekeres, Mikkael A.
    BLOOD, 2019, 134
  • [49] An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia
    Othman, Tamer A.
    Tenold, Matthew E.
    Moskoff, Benjamin N.
    Azenkot, Tali
    Jonas, Brian A.
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (05) : 407 - 417
  • [50] Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients
    Faderl, Stefan
    Ravandi, Farhad
    Huang, Xuelin
    Wang, Xuemei
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Kadia, Tapan
    Ferrajoli, Alessandra
    Konopleva, Marina
    Borthakur, Gautam
    Burger, Jan
    Feliu, Jennie
    Kantarjian, Hagop M.
    CANCER, 2012, 118 (18) : 4471 - 4477
12345